Nanoparticle-based artificial RNA silencing machinery for antiviral therapy

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 31, 2012, Pages 12387-12392

  Wang, Zhongliang ^a   Liu, Hongyan ^b   Yang, Soon Hye ^a   Wang, Tie ^a   Liu, Chen ^b   Cao, Y Charles ^a  

^a University of Florida ^*  (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Endoribonuclease; Gene therapy; Nanomedicine

Indexed keywords

NANOPARTICLE; RNA INDUCED SILENCING COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; ARTICLE; GENE SILENCING; GENE TARGETING; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA CLEAVAGE; SEQUENCE ANALYSIS; TUMOR XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; HEPACIVIRUS; HEPATITIS C; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NANOPARTICLES; NEOPLASM TRANSPLANTATION; RNA INTERFERENCE; RNA, VIRAL; RNA-INDUCED SILENCING COMPLEX; TRANSPLANTATION, HETEROLOGOUS;

HEPATITIS C VIRUS; MUS;

EID: 84864528511     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1207766109     Document Type: Article

References (36)

1. Peer D, et al. (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2:751-760. (Pubitemid 350223348)
2. Giljohann DA, et al. (2010) Gold nanoparticles for biology and medicine. Angew Chem Int Edit 49:3280-3294.
3. Alivisatos P (2004) The use of nanocrystals in biological detection. Nat Biotechnol 22:47-52.
4. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H (2005) Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater 4:435-446. (Pubitemid 40774047)
5. Nederberg F, et al. (2011) Biodegradable nanostructures with selective lysis of microbial membranes. Nat Chem 3:409-414.
6. Qian XM, et al. (2008) In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 26:83-90.
7. Wu W, Li AD (2007) Optically switchable nanoparticles for biological imaging. Nanomedicine (Lond) 2:523-531. (Pubitemid 47365127)
8. Graham D, Thompson DG, Smith WE, Faulds K (2008) Control of enhanced Raman scattering using a DNA-based assembly process of dye-coded nanoparticles. Nat Nanotechnol 3:548-551.
9. Cho EC, Zhang Q, Xia YN (2011) The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol 6:385-391.
10. Kim B, et al. (2010) Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat Nanotechnol 5:465-472.
11. Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54:631-651. (Pubitemid 35247520)
12. Yezhelyev MV, Qi LF, O'Regan RM, Nie S, Gao XH (2008) Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. J Am Chem Soc 130:9006-9012. (Pubitemid 352000838)
13. Khaled A, Guo SC, Li F, Guo PX (2005) Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology. Nano Lett 5:1797-1808. (Pubitemid 41396168)
14. Shu D, Shu Y, Haque F, Abdelmawla S, Guo PX (2011) Thermodynamically stable RNA three-way junction for constructing multifunctional nanoparticles for delivery of therapeutics. Nat Nanotechnol 6:658-667.
15. Moazed D (2009) Small RNAs in transcriptional gene silencing and genome defence. Nature 457:413-420.
16. Park SJ, Taton TA, Mirkin CA (2002) Array-based electrical detection of DNA with nanoparticle probes. Science 295:1503-1506. (Pubitemid 34174000)
17. Pan Y, et al. (2007) Size-dependent cytotoxicity of gold nanoparticles. Small 3:1941-1949. (Pubitemid 350099867)
18. Rosi NL, et al. (2006) Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312:1027-1030.
19. Alberts B (2008) Molecular Biology of the Cell (Garland Science, New York), 5th Ed.
20. Bendayan M (1989) "The Enzyme-Gold Cytochemical Approach: A Review"in Colloidal Gold Principles, Methods, and Applications, edMA Hayat (Academic Press, San Diego), Vol. 2, pp 117-147.
21. Tsai WL, Chung RT (2010) Viral hepatocarcinogenesis. Oncogene 29:2309-2324.
22. Lanford RE, et al. (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327:198-201.
23. Ploss A, Rice CM (2009) Towards a small animal model for hepatitis C. EMBO Rep 10:1220-1227.
24. McMullan LK, et al. (2007) Evidence for a functional RNA element in the hepatitis C virus core gene. Proc Natl Acad Sci USA 104:2879-2884. (Pubitemid 46327973)
25. Yokota T, et al. (2003) Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep 4:602-608. (Pubitemid 36939952)
26. Demers LM, Mucic RC, Reynolds RA, Mirkin CA, Letsinger RL (2000) Fluorescence-based method for the determination of surface coverage and hybridization efficiency of thiol-capped oligonucleotides bound to gold nanoparticles. Abstr Pap Am Chem Soc 219:U870-U870.
27. Lazarides AA, Schatz GC (2000) DNA-linked metal nanosphere materials: Structural basis for the optical properties. J Phys Chem B 104:460-467.
28. Cerritelli SM, Crouch RJ (2009) Ribonuclease H: The enzymes in eukaryotes. FEBS J 276:1494-1505.
29. Kelly BM, Yu CZ, Chang PL (1989) Presence of a lysosomal-enzyme, arylsulfatase-a, in the prelysosome-endosome compartments of human cultured fibroblasts. Eur J Cell Biol 48:71-78.
30. Randall G, Grakoui A, Rice CM (2003) Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci USA 100:235-240. (Pubitemid 36078058)
31. Kobe B, Deisenhofer J (1996) Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A. J Mol Biol 264:1028-1043. (Pubitemid 27019490)
32. Marques JT, Williams BRG (2005) Activation of the mammalian immune system by siRNAs. Nat Biotechnol 23:1399-1405. (Pubitemid 41679392)
33. Zhu HZ, et al. (2003) Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 37:1180-1188.
34. Kanda T, Steele R, Ray R, Ray RB (2007) Small interfering RNA targeted to hepatitis C virus 5′ nontranslated region exerts potent antiviral effect. J Virol 81:669-676. (Pubitemid 46067893)
35. Lindenbach BD, Rice CM (2005) Unravelling hepatitis C virus replication from genome to function. Nature 436:933-938. (Pubitemid 41191668)
36. Changeux JP, Edelstein SJ (2005) Allosteric mechanisms of signal transduction. Science 308:1424-1428.